Skip to main content
. Author manuscript; available in PMC: 2019 Mar 6.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):13–24. doi: 10.1097/PAI.0b013e31821c821c

FIGURE 4.

FIGURE 4.

Kaplan-Meier survival curves: (A) all patients, (B) survival by HER2 status (positive vs. negative), (C) survival by site (gastric vs. gastroesophageal junction). Median overall survival for the study population is 34 months and 5-year survival is 25%. There were no differences in survival by site or HER2 status.